Sunesis Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
13 May 2008 - 10:00PM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., May 13 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that
Eric Bjerkholt, Sunesis' Senior Vice President, Corporate
Development and Finance, will provide a corporate update at the
upcoming Rodman & Renshaw 5th Annual Global Healthcare
Conference at 9:00 a.m. local time on Monday, May 19, 2008 at the
Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. Interested
parties may access a webcast of the presentation by visiting the
Sunesis website at http://ir.sunesis.com/. A replay of the webcast
will be archived on the "Calendar of Events" page in the Investors
and Media section of the Sunesis website for two weeks. About
Sunesis Pharmaceuticals Sunesis is a clinical-stage
biopharmaceutical company focused on the discovery, development and
commercialization of novel small molecule therapeutics for oncology
and other serious diseases. Sunesis has built a broad product
candidate portfolio through internal discovery and in-licensing of
novel cancer therapeutics. Sunesis is advancing its product
candidates through in-house research and development efforts and
strategic collaborations with leading pharmaceutical and
biopharmaceutical companies. For further information on Sunesis
Pharmaceuticals, please visit http://www.sunesis.com/. DATASOURCE:
Sunesis Pharmaceuticals, Inc. CONTACT: investors, Eric Bjerkholt,
SVP, Corp. Development & Finance of Sunesis Pharmaceuticals,
Inc., +1-650-266-3717; or media, Karen L. Bergman, +1-650-575-1509,
or Michelle Corral, +1-415-794-8662, both of BCC Partners, for
Sunesis Pharmaceuticals, Inc. Web site: http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Sunesis Pharmaceuticals (MM) News Articles